Fundraising FoxHelios Climate Ventures — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
TechsoMedtechsomed.cominSeed · Jan 2018 · $1M
TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsNextLeap VenturesAxil Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
EmerjGamitee
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.